Master Protocols, Adaptive Designs, and Bayesian Statistics: These innovative trial approaches are sometimes described as being “patient-centric.” Are they? What are the challenges and opportunities for patient groups to support them?

Moderator

Sara Calvert
Project Manager, CTTI

Speakers

Amy Burd
Principal, Beat AML Trial, Leukemia & Lymphoma Society

Melanie Quintana
Director & Senior Statistical Scientist, Berry Consultants, LLC

Pat Furlong
President and CEO, Parent Project Muscular Dystrophy

This recording is from the TRAIN workshop held on November 8, 2021 entitled 'Foundations’ Role in Supporting Clinical Trial Innovation' that was collaboratively run by FasterCures and the Clinical Trial Transformation Initiative (CTTI).